Company profile
Actelion Pharmaceuticals company profile
Actelion Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of low molecular weight drugs for various medical needs. Its principal products include Tracleer, an orally available dual endothelin receptor antagonist, approved as a therapy for pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder that severely compromises the functions of the lungs and heart; and Zavesca, in-licensed from Oxford GlycoSciences, an oral medication indicated for the oral treatment of adult patients with mild to moderate type 1 Gaucher disease. The company also offers Ventavis, an inhaled synthetic analogue of prostacyclin that produces potent pulmonary vasodilation and inhibits platelet..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- http://www.actelion.com
- Phone number
- (416) 156-5656
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 05001-10000 employees
- Founded
- 1997-01-01
Headquarters
- Headquarters
- Allschwil, Basel-Landschaft, Switzerland
- Postal code
- CH-4123
- Country code
- CH
- Continent
- Europe